Literature DB >> 11522397

Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration.

A A Vyas1, R L Schnaar.   

Abstract

Gangliosides, sialylated glycosphingolipids which are the predominant glycans on vertebrate nerve cell surfaces, are emerging as components of membrane rafts, where they can mediate important physiological functions. Myelin associated glycoprotein (MAG), a minor constituent of myelin, is a sialic acid binding lectin with two established physiological functions: it is involved in myelin-axon stability and cytoarchitecture, and controls nerve regeneration. MAG is found selectively on the myelin membranes directly apposed to the axon surface, where it has been proposed to mediate myelin-axon interactions. Although the nerve cell surface ligands for MAG remain to be established, evidence supports a functional role for sialylated glycoconjugates. Here we review recent studies that reflect on the role of gangliosides, sialylated glycosphingolipids, as functional MAG ligands. MAG binds to gangliosides with the terminal sequence 'NeuAc alpha 3Gal beta 3GalNAc' which is found on the major nerve gangliosides GD1a and GT1b. Gangliosides lacking that terminus (e.g., GM1 or GD1b), or having any biochemical modification of the terminal NeuAc residue fail to support MAG binding. Genetically engineered mice lacking the GalNAc transferase required for biosynthesis of the 'NeuAc alpha 3Gal beta 3GalNAc' terminus have grossly impaired myelination and progressive neurodegeneration. Notably the MAG level in these animals is dysregulated. Furthermore, removal of NeuAc residues from nerve cells reverses MAG-mediated inhibition of neuritogenesis, and neurons from mice lacking the 'NeuAc alpha 3 Gal beta 3GalNAc' terminus have an attenuated response to MAG. Cross-linking nerve cell surface gangliosides can mimic MAG-mediated inhibition of nerve regeneration. Taken together these observations implicate gangliosides as functional MAG ligands.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522397     DOI: 10.1016/s0300-9084(01)01308-6

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  33 in total

1.  Total sialic acid levels decrease in the periventricular area of infantile rats with hydrocephalus.

Authors:  T Erhan Cosan
Journal:  Childs Nerv Syst       Date:  2003-11-13       Impact factor: 1.475

2.  The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.

Authors:  Karthik Venkatesh; Onanong Chivatakarn; Hakjoo Lee; Pushkar S Joshi; David B Kantor; Barbara A Newman; Rose Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

3.  Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions.

Authors:  Tadashi Yamashita; Yun-Ping Wu; Roger Sandhoff; Norbert Werth; Hiroki Mizukami; Jessica M Ellis; Jeffrey L Dupree; Rudolf Geyer; Konrad Sandhoff; Richard L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Structural and kinetic analysis of substrate binding to the sialyltransferase Cst-II from Campylobacter jejuni.

Authors:  Ho Jun Lee; Luke L Lairson; Jamie R Rich; Emilie Lameignere; Warren W Wakarchuk; Stephen G Withers; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

5.  Sequential One-Pot Multienzyme Chemoenzymatic Synthesis of Glycosphingolipid Glycans.

Authors:  Hai Yu; Yanhong Li; Jie Zeng; Vireak Thon; Dung M Nguyen; Thao Ly; Hui Yu Kuang; Alice Ngo; Xi Chen
Journal:  J Org Chem       Date:  2016-10-24       Impact factor: 4.354

6.  Effects of gangliosides on the activity of the plasma membrane Ca2+-ATPase.

Authors:  Lei Jiang; Misty D Bechtel; Jennifer L Bean; Robert Winefield; Todd D Williams; Asma Zaidi; Elias K Michaelis; Mary L Michaelis
Journal:  Biochim Biophys Acta       Date:  2014-01-14

7.  Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.

Authors:  Richard Jennemann; Roger Sandhoff; Shijun Wang; Eva Kiss; Norbert Gretz; Cecilia Zuliani; Ana Martin-Villalba; Richard Jäger; Hubert Schorle; Marc Kenzelmann; Mahnaz Bonrouhi; Herbert Wiegandt; Hermann-Josef Gröne
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

8.  The lysosomal sialic acid transporter sialin is required for normal CNS myelination.

Authors:  Laura M Prolo; Hannes Vogel; Richard J Reimer
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

Review 9.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 10.  Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.

Authors:  Roman J Giger; Karthik Venkatesh; Onanong Chivatakarn; Stephen J Raiker; Laurie Robak; Thomas Hofer; Hakjoo Lee; Christoph Rader
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.